Sarah Lensen

ORCID: 0000-0002-1694-1142 · 9 papers in corpus
other 2024
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14876

INTRODUCTION: "Improvement in the most bothersome symptom" was recently selected as a core outcome for endometriosis intervention trials. This study aimed to explore the applicability of the construct of "symptom bother" in representing the…

other 2024
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14927

INTRODUCTION: There is considerable variation in the types of symptoms experienced by people living with endometriosis, and it is unclear which symptoms impact people the most. This study aimed to identify the specific symptoms that are "mo…

2024
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deae147

Study questionWhat is the impact of co-designed, evidence-based information regarding the anti-Mullerian hormone (AMH) test on women's interest in having the test?Summary answerWomen who viewed the evidence-based information about the AMH t…

2023
Human Reproduction Update ·doi:10.1093/humupd/dmad014

BackgroundIn IVF/ICSI treatment, the process of embryo implantation is the success rate-limiting step. Endometrial scratching has been suggested to improve this process, but it is unclear if this procedure increases the chance of implantati…

2022
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deac030

Infertility randomized controlled trials (RCTs) are often too small to detect realistic treatment effects. Large observational studies have been proposed as a solution. However, this strategy threatens to weaken the evidence base further, b…

2022
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.13576

BackgroundAdd-ons at the time of in vitro fertilisation (IVF) have become commonplace, despite a general lack of evidence that they are effective and safe. The 'Colorado Protocol' is a commonly used add-on consisting of aspirin, steroid and…

2021
BMJ open ·doi:10.1136/bmjopen-2020-046927

ObjectivesThe anti-Mullerian hormone (AMH) test has been promoted as a way to inform women about their future fertility. However, data consistently show the test is a poor predictor of natural fertility potential for an individual woman. As…

2020
Human reproduction open ·doi:10.1093/hropen/hoaa037

Study questionsIn couples with unexplained infertility and a poor prognosis of natural conception, are four cycles of IUI with ovarian stimulation (IUI-OS) non-inferior to one completed cycle of IVF for the outcome of cumulative live birth?…

article 2018
·doi:10.1002/14651858.cd013180

This is a protocol for a Cochrane Review (Overview). The objectives are as follows: To identify, systematically assess and summarise all evidence from Cochrane Reviews on treatment for heavy menstrual bleeding (HMB), through a network meta‐…